Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AKTS | BCAX |
|---|---|---|
| Price | $18.00 | $16.42 |
| Change today | ▲ 0.78% | ▼ 0.85% |
| Market cap | $1.00B | $1.09B |
| Return, 3 months | -36.7% | -44.7% |
| Return, year to date | – | -2.4% |
| Return, 1 year | – | -8.8% |
| P/E (TTM) | -13.2 | -5.3 |
| P/B | 2.1 | 2.3 |
| P/E percentile vs own 5y | 97th | 98th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +111.4% | – |
| Net profit growth (YoY) | -33.6% | -102.4% |
| Gross margin | – | – |
| Operating margin | -866.6% | – |
| Net margin | -727.0% | – |
| Return on equity | -15.1% | -41.0% |
| Analyst target vs. price | +98.9% | +123.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 25 | 20 |
| 30-day volatility | 48.9% | 43.7% |
| Max drawdown, 1 year | -44.6% | -46.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
